Related Experiment Video
Updated: Mar 15, 2026
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Study
Anti-N-methyl-D-aspartate receptor encephalitis is an autoimmune disorder causing psychosis, seizures, and catatonia. Treatment involves tumor resection, immunosuppression, and managing autonomic storming with cooling and medication.
Area of Science:
- Neuroscience
- Immunology
- Autoimmune Diseases
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neurological disorder.
- It is characterized by psychiatric symptoms, seizures, movement disorders, and autonomic dysfunction.
Observation:
- This case study details a patient with confirmed anti-NMDAR encephalitis.
- The patient experienced progressive psychosis, seizures, catatonia, abnormal movements, and autonomic instability.
Findings:
- Standard treatments include tumor resection, corticosteroids, IV immunoglobulin, plasma exchange, rituximab, and cyclophosphamide.
- Autonomic storming, a critical feature, can be managed with surface cooling and specific pharmaceutical regimens.
Implications:
- Effective management requires addressing both the autoimmune process and its severe systemic manifestations.
- Nursing care is crucial during immunosuppression, focusing on monitoring and supportive interventions.
- This case highlights diagnostic and therapeutic challenges and emphasizes tailored treatment strategies.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022